Thrombocytosis associated with enoxaparin: A very rare cause in newborns.

Autor:	Tonbul A; Fatih University School of Medicine, Department of Pediatrics, Division of Neonatology, Ankara, Turkey., Uras N, Tayman C, Halici T, Polat A, Mansur Tatli M
Jazyk:	angličtina
Zdroj:	Platelets [Platelets] 2010; Vol. 21 (4), pp. 300-2.
DOI:	10.3109/09537101003649807
Abstrakt:	Newborn infants are most vulnerable to the development of thrombosis because of the developing neonatal hemostatic system, perinatal risk factors and different types of medical conditions. Enoxaparin is the current anticoagulant of choice with advantages for the treatment of neonatal thrombosis. Thrombocytosis induced by enoxaparin has been reported as a rare adverse effect of this medication in adults. However, to our knowledge, in newborns there have been no reported cases to date of thrombocytosis induced by enoxaparin.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu Plný text ve formátu PDF Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.